Statistics
Total Visits
Views | |
---|---|
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group | 128 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group | 3 | 0 | 1 | 4 | 0 | 5 | 1 |
Top country views
Views | |
---|---|
Poland | 62 |
United States | 44 |
China | 7 |
France | 4 |
Sweden | 4 |
Germany | 2 |
Ireland | 2 |
Australia | 1 |
India | 1 |
Top cities views
Views | |
---|---|
Warsaw | 62 |
Boardman | 7 |
San Ramon | 7 |
San Diego | 5 |
Ann Arbor | 4 |
Beijing | 4 |
San Mateo | 4 |
Des Moines | 3 |
Mountain View | 3 |
Dublin | 2 |